Progress in Signaling Pathways Associated to Irritable Bowel Syndrome
DOI:
https://doi.org/10.53469/jcmp.2024.06(08).41Keywords:
Irritable bowel syndrome, Signaling pathway, Research progressAbstract
Irritable bowel syndrome (IBS) is the most common chronic functional bowel disease with abdominal pain and diarrhea as the main symptoms. Its course develops repeatedly, which seriously affects the quality of life of patients. At present, it occupies a large amount of medical resources, but its onset and etiology is not completely clear. It is currently believed that visceral hypersensitivity, brain-gut axis and gastrointestinal motility abnormalities are their important pathophysiology bases. In recent years, recent studies show that the signaling pathways in viscera and brain-gut axis, such as 5-HT, NF- κb, topv 1 and MAPK, have important effects on IBS. It can repair intestinal inflammation, reduce visceral sensitivity, enhance intestinal mucosal barrier and regulate intestinal power through the regulation of these series of signaling pathways, and plays an important role in multi-level, multi-link and multi-target treatment of IBS. Based on the signal pathway, this paper summarizes the research progress of IBS signal pathway in recent years, in order to provide theoretical support and diagnosis and treatment ideas for the clinical treatment of TCM in IBS.
References
Yao Xin, Yang Yunsheng, Zhao KBING, et al. Study on clinical characteristics and subtypes of irritable bowel syndrome using Rome III criteria [J]. International Journal of Chinese Digestion, 2008,16 (5): 563-566.
FORDAC LACYBE, TALLEYNJ. Irritablebowelsyn - drome [J]. J NEngl J Med, 2017376 (26): 2566-2578.
Wu Haomeng, Tang Xudong, Wang Fengyun, et al. The mechanism of autophagy on visceral hypersensitivity in diarrheal irritable bowel syndrome [J]. Chinese Journal of Traditional Chinese Medicine, 2019,35(12): 6261-6264.
REA K, O'MAHONYS M, DINAN T G, et al. The role of The gastrointestinal microbiota in visceral pain [J].Handb Exp Pharmacol, 2017239:269-287.
FORD A C, SPERBER A D, CORSETTI M, et al. Irritable bowel syndrome [J]. Lancet, 2020,396 (10263): 1675-1688.
FRITZ N, BERENS S, DONG Y, et al. The serotonin receptor 3E variant is a risk factor for female IBS-D [J]. J Mol Med (Berl), 2022,100 (11): 1617-1627.
BELLONO N W, BAYRER J R, LEITCH D B, et al. Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell, 2017,170 (1): 185-198.
KIM D Y, CAMILLERI M. Serotonin: A mediator of the brain-gut connectio [J]. Am J Gastroenterol, 2000,95 (10): 2698-2709.
KENNEDY P J, CLARKE G, QUIGLEY E M, et al. Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome [J]. Neurosci Biobehav Rev, 2012,36 (1): 310-340.
MISHIMA Y, ISHIHARA S. Enteric microbiotamediated serotonergic signaling in pathogenesis of irritable bowel syndrome [J]. Int J Mol Sci, 201, 22 (19): 10235
Zheng Xue, Zhi Mujun, Zhao Li-Li, et al. Study on the mechanism of natural moxibustion therapy in the treatment of mice with visceral hypersensitivity irritable bowel syndrome based on 5-HT channel [J]. Chinese Journal of Acupuncture and Moxibustion, 202,42(7):773-778
Zhu Xiaoqin, Liu Guangyao, Zeng Qiying, Qin Dongyuan, Zhou Xueqi, ZHANG Yu, Zhang Dekui. Research progress of serotonin and irritable bowel syndrome [J]. Medical Review, 2022, 28 (12): 2482-2486.
Cao J N, LIU X, LIU T, et al. Effects of moxibustion on colon 5-HT and 5-HT3R in rats with diarrheal irritable bowel syndrome [J]. Journal of Hunan University of Traditional Chinese Medicine, 2019, 41 (10): 1493-1497.
Ouyang Yong-wen, Li Zhao-tao, Lv Jin, et al. Effects of fecal bacteria transplantation on 5-HT signaling pathway in brain-gut axis of diarrheal irritable bowel syndrome model rats [J]. International Journal of Laboratory Medicine, 2022, 43 (16): 1994-1999.
Zhang JX, Rui JQ, Chen YIFan, et al. Multi-target synergistic regulation of active components of Sini SAN on 5-HT signaling pathway in splanchnic hypersensitive rats [J]. Chinese Journal of Experimental Formulae, 2018,24 (16): 115-123.
Liang Guoqiang, Zhang Yifan, Ge Huinan, et al. Study on the regulatory effect of Wumen YJ Powder on the 5-hydroxytryptamine signaling system in the gut and hypothalamus of rats with diarrheal irritable bowel syndrome [J]. International Journal of Traditional Chinese Medicine, 201, 43 (11): 1089-1096.
Sun Yan-ning, Fu Mei-Zhu. Effect of total glucosides of Paeony on 5-HT signaling pathway in rats with diarrhea-type irritable bowel syndrome [J]. Western Chinese Medicine, 2023, 36 (06): 14-18.
Wei XX, Yi Mengni, Deng Na, et al. Effect of Sishen Pills on the expression of 5-HT signaling pathway in rats with diarrheal irritable bowel syndrome [J]. Chinese Emergency of Traditional Chinese Medicine, 2024, 33 (02): 215-218.
Zeng W W, Wang Y J, Zou L, et al. The role of Bmal1 in irritable bowel syndrome through enterochromaffin cells and its TPH1-5-HT signaling pathway [J]. Gastroenterology, 2022, 27 (06): 321-327.
Brown PM, Drossman DA, Wood AJ, et al. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome [J]. Gastroenterology, 2011,141(2):507-516.
Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI Disorders [J]. Gastroenterology, 2007132 (1): 397-414.
Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome [J]. Clin Chim Acta, 2009403 (1-2): 47 and 55.
Shang Y N, Lu W T, Zhang L L, et al. Analysis and consideration on the mechanism of moxibustion regulating NF-κB signaling pathway [J]. Asian-pacific Traditional Medicine, 2019,16(12): 202-205.
Liu Jing, Huang Zheng, Zhang Genhong. Acupuncture regulation of NF-κB signaling pathway to improve symptoms and its mechanism in patients with rheumatoid arthritis [J]. Journal of Acupuncture Research, 2020, 45(11): 914-919.
He X, Cui LH, Wang XH, et al. Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome [J]. Oncotarget, 2017, 8(69): 113957-113965.
Zhu W, Zeng T T. Intervention mechanism of Shenlingbaizhu powder on IBS-D rats based on TLR4/MyD88/NF-κB signaling pathway [J]. Hunan Chinese medicine journal, 2023, 33 (12): 6. 128-134 DOI: 10.16808 / j.carol carroll nki issn1003-7705.2023.12.032.
He Xing. The role and mechanism of TLR4/NF-κB signaling pathway in diarrheal irritable bowel syndrome [D]. The Chinese people's liberation army (PLA) army military medical university in 2018. The DOI: 10.27001 / dc nki. Gtjyu. 2018.000055.
Zhang Yujie, Pei Lixia, Zhou Junling, et al. Study on the mechanism of electroacupuncture regulating the inflammatory response of Akt/NF-κB signaling pathway in repairing damaged intestinal mucosal barrier [J]. Information of Chinese Medicine, 2021,38 (7): 9-17.
Wang Yu, Chen Xia, Wu Libin, et al. Effect of moxibustion on IKKβ/ IKKα /NF-κB pathway in hippocampal and colonic tissues of rats with diarrheal irritable bowel syndrome [J]. Journal of Anhui University of Traditional Chinese Medicine, 2019, 39 (3): 32-36
Fu Rong-Peng, Ning Xiao-Ying, Wu Yuan, et al. Efficacy and mechanism of Anchang Decoction combined with moxibustion in treating diarrheal irritable bowel syndrome of liver-Yu and spleen-deficiency syndrome based on TLR4/MyD88/NF-κB signaling pathway [J]. Modern biomedical progress, 2024, 24 (3): 470-474. The DOI: 10.13241 / j.carol carroll nki PMB. 2024.03.013.
Li Y W, Zhao J M, Chen Liu, et al. Effect of electroacupuncture and moxibustion on the expression of capsaicin receptor and heat shock protein 70 in viscera hypersensitive rats and its analgesic effect [J]. Acupuncture Research,2016,41(4):291-297.
Deng D X, Tan J, Zhang H, et al. Effects of acupuncture at He-mu matching points on colonic visceral hypersensitivity related factors in rats with irritable bowel syndrome [J]. Acupuncture Research, 2018,43 (8): 485-491.
He Yuxi, Tang Zhaorong, Wu Yue, et al. Tongxieyaofang improves visceral hypersensitivity in rats with diarrhea-type irritable bowel syndrome through miR-199/TRPV1 signaling pathway [J]. World combine traditional Chinese and western medicine, 2023, 18 (4): 687-691 + 718. DOI: 10.13935 / j.carol carroll nki SJZX. 230411.
Han YAFei, Shi Lei, Jia Boyi, et al. Intervention effect of Tongxiean Chang Prescription on NGF/PLC-γ/TRPV1 signaling pathway expression in diarrheal irritable bowel syndrome model rats [J]. Chinese Emergency of Traditional Chinese Medicine, 2017, 26 (12): 2069-2073.
Chen J Y, Wang C, Wang J, et al. Research progress of MAPK signaling pathway [J]. China Medical Sciences, 2011, 1 (08): 32-34.
Wu N P, Sun H X, Yang X D, et al. Prospect of MAPK signaling pathway and targeting of intestinal diseases [J]. Chinese Journal of Immunology, 2016,32 (3): 299-306
Guo JX, Ma L, Kang WR, et al. Effect of Tongxieyao Formula on the expression of p38MAPK signaling pathway related proteins and their target genes in colonic tissues of rats with liver-stagnation and spleen-deficiency syndrome [J]. Chinese Journal of Experimental Formulae,20,26(4):1-8.
Sun Zhen-Tao, Zhang Xiao-Yuan. Advances in research on signaling pathways associated with diarrheal irritable bowel syndrome [J]. Chinese Journal of Inter-cellular Therapy, 2023, 31 (23): 109-113. DOI:10.19621/j.cnki.11-3555/r.2023.2334.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yizhuo Gao, Fang Li, Tao Yu
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
